Navigation Links
Frost & Sullivan Recognizes GE Healthcare for Strategic Leadership in Acquiring Dynamic Imaging to Grow Its Imaging Informatics Business
Date:3/19/2009

MOUNTAIN VIEW, Calif., March 19 /PRNewswire/ -- Based on its recent analysis of the medical imaging market, Frost & Sullivan presents GE Healthcare with the 2009 North American Frost & Sullivan Award for "Growth Strategy Leadership of the Year." The honor serves as recognition of the growth path that GE's imaging informatics business has embarked upon since the firm's acquisition of Dynamic Imaging (DI) in October 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

"The DI acquisition has provided GE with leading edge RIS/PACS technology and a winning business model that have consistently earned the appraisal of the market," says Frost & Sullivan Senior Industry Analyst Nadim Daher. "By capitalizing effectively on this strategic acquisition throughout the subsequent year, GE Healthcare has been able to stimulate its imaging informatics business despite challenging market conditions and saturation, while strengthening its leadership position in both the North American and global imaging informatics markets."

During the past year the newly-branded Dynamic Imaging Solutions division has helped GE Healthcare drive significant customer growth across all segments of the North American healthcare provider market including hospitals, outpatient imaging centers and physician offices. Further, the unique ability to offer Web-based RIS/PACS for any size hospital or outpatient imaging market (based upon Centricity RIS-IC and DI's acquired outpatient imaging center RIS, respectively) is a "sweet spot" in the industry, considering the increasing saturation in the PACS market and the opportune lower end of the spectrum, left otherwise underserved by GE prior to the acquisition.

Shortly after the acquisition, GE Healthcare re-branded DI's IntegradWeb PACS as GE Centricity PACS-IW. In early 2008, they be
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Supernanny Jo Frost Joins the Partnership for a Drug-Free America in Supporting Time To Talk(TM)
2. Masimo Corporation Receives a Frost & Sullivan 2007 Industry Best Practices Award for Pulse Oximetry Leadership
3. Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award
4. Novadaqs SPY Imaging System named Product of the Year by Frost and Sullivan
5. Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan
6. Kelloggs Frosted Flakes Gold(TM) Helps Moms Get the Gold
7. MedApps Receives Prestigious Frost & Sullivan Award
8. Nancy Frost Joins Lawson-Hawks as Employee Benefits Vice President
9. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
10. Help Your Kids Earn an A for Attentiveness with a Bowl of Frosted Mini- Wheats(R) Cereal for Breakfast
11. Therapy Could Save Limbs After Frostbite
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Webcast of QIAGEN N V s 28Nasdaq 3A QGEN 29 Second Quarter 2009 Financial Results Call Set for August 11 13355 1Webcast of QIAGEN N V s 28Nasdaq 3A QGEN 29 Second Quarter 2009 Financial Results Call Set for August 11 13355 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 1VIASPACE Pursuing Renewable Energy Business in Asia 13353 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 1Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 4Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 5Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 6